Search

Your search keyword '"Nakamura, Ryotaro"' showing total 1 results
Start Over Author "Nakamura, Ryotaro" Publication Year Range Last 3 years Journal journal of infectious diseases
1 results on '"Nakamura, Ryotaro"'

1. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience.

Author

Puing, Alfredo G, Ho, Stephanie, Frankel, Paul, Tegtmeier, Bernard, Martin, Abigail, Ross, Justine, Nanayakkara, Deepa, Dickter, Jana, Seto, Tyler, Nakamura, Ryotaro, Taplitz, Randy, and Dadwal, Sanjeet

Subjects
COVID-19, PATIENTS' attitudes, MONOCLONAL antibodies, CANCER patients
Abstract

Only 1 (3%) patient, a CAR-T therapy recipient for diffuse large B-cell lymphoma, treated with bamlanivimab for mild COVID-19 progressed to severe disease requiring ICU care. To the Editor - We read with interest the article by Ganesh et al regarding monoclonal antibody (mAb) therapy for coronavirus disease 2019 (COVID-19) in high-risk patients [[1]]. Coronavirus (COVID-19) update: FDA authorizes monoclonal antibodies for treatment of COVID-19. 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibody-treatment-covid-19. [Extracted from the article]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results